144 related articles for article (PubMed ID: 25106465)
1. [¹⁸F-NaF PET-CT: a new method for imaging of ruptured and rupture-endangered atherosclerotic plaques].
Avanesov M; Karul M; Derlin T
Radiologe; 2014 Sep; 54(9):856-8. PubMed ID: 25106465
[No Abstract] [Full Text] [Related]
2. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.
Joshi NV; Vesey AT; Williams MC; Shah AS; Calvert PA; Craighead FH; Yeoh SE; Wallace W; Salter D; Fletcher AM; van Beek EJ; Flapan AD; Uren NG; Behan MW; Cruden NL; Mills NL; Fox KA; Rudd JH; Dweck MR; Newby DE
Lancet; 2014 Feb; 383(9918):705-13. PubMed ID: 24224999
[TBL] [Abstract][Full Text] [Related]
3. A new frontier in atherosclerotic coronary imaging.
Thomas GS; Haraszti RA
Lancet; 2014 Feb; 383(9918):674-5. PubMed ID: 24225000
[No Abstract] [Full Text] [Related]
4. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
Chen W; Dilsizian V
Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466
[TBL] [Abstract][Full Text] [Related]
5. Vulnerable plaque imaging using
Kwiecinski J; Slomka PJ; Dweck MR; Newby DE; Berman DS
Br J Radiol; 2020 Sep; 93(1113):20190797. PubMed ID: 31804143
[TBL] [Abstract][Full Text] [Related]
6. Clinical Relevance of
Lee JM; Bang JI; Koo BK; Hwang D; Park J; Zhang J; Yaliang T; Suh M; Paeng JC; Shiono Y; Kubo T; Akasaka T
Circ Cardiovasc Imaging; 2017 Nov; 10(11):. PubMed ID: 29133478
[TBL] [Abstract][Full Text] [Related]
7. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerotic plaque metabolism in high cardiovascular risk subjects - A subclinical atherosclerosis imaging study with
Oliveira-Santos M; Castelo-Branco M; Silva R; Gomes A; Chichorro N; Abrunhosa A; Donato P; Pedroso de Lima J; Pego M; Gonçalves L; Ferreira MJ
Atherosclerosis; 2017 May; 260():41-46. PubMed ID: 28349887
[TBL] [Abstract][Full Text] [Related]
9.
Kitagawa T; Yamamoto H; Toshimitsu S; Sasaki K; Senoo A; Kubo Y; Tatsugami F; Awai K; Hirokawa Y; Kihara Y
Atherosclerosis; 2017 Aug; 263():385-392. PubMed ID: 28528743
[TBL] [Abstract][Full Text] [Related]
10.
Youn T; Al'Aref SJ; Narula N; Salvatore S; Pisapia D; Dweck MR; Narula J; Lin FY; Lu Y; Kumar A; Virmani R; Min JK
Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):404-411. PubMed ID: 31875701
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Somatostatin Receptor 2-Targeting PET Tracers in the Detection of Mouse Atherosclerotic Plaques.
Rinne P; Hellberg S; Kiugel M; Virta J; Li XG; Käkelä M; Helariutta K; Luoto P; Liljenbäck H; Hakovirta H; Gardberg M; Airaksinen AJ; Knuuti J; Saraste A; Roivainen A
Mol Imaging Biol; 2016 Feb; 18(1):99-108. PubMed ID: 26122428
[TBL] [Abstract][Full Text] [Related]
12. Complementary value of cardiac FDG PET and CT for the characterization of atherosclerotic disease.
Stolzmann P; Subramanian S; Abdelbaky A; Maurovich-Horvat P; Scheffel H; Tawakol A; Hoffmann U
Radiographics; 2011; 31(5):1255-69. PubMed ID: 21918043
[TBL] [Abstract][Full Text] [Related]
13. Imaging of vulnerable plaques: will it affect patient management and influence outcomes?
Beller GA
J Nucl Cardiol; 2011 Aug; 18(4):531-3. PubMed ID: 21678112
[No Abstract] [Full Text] [Related]
14. Molecular imaging of the atherosclerotic plaque using positron emission tomography.
Toor IS; Dweck MR; Newby DE
J R Coll Physicians Edinb; 2014; 44(2):139-45. PubMed ID: 24999778
[TBL] [Abstract][Full Text] [Related]
15. Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective.
Krishnan S; Otaki Y; Doris M; Slipczuk L; Arnson Y; Rubeaux M; Dey D; Slomka P; Berman DS; Tamarappoo B
J Nucl Med; 2017 Mar; 58(3):359-364. PubMed ID: 28183988
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Molecular Imaging of Ruptured Coronary Atherosclerotic Plaque Using IVUS, OCT, and FDG-PET/CT.
Koiwaya H; Tahara N; Tahara A; Honda A; Igata S; Bekki M; Nakamura T; Sugiyama Y; Ohtsuka M; Kurata S; Fujimoto K; Abe T; Shibata Y; Ueno T; Fukumoto Y
JACC Cardiovasc Interv; 2016 Jun; 9(12):e113-e115. PubMed ID: 27262867
[No Abstract] [Full Text] [Related]
17. Predictive Value of
Kitagawa T; Yamamoto H; Nakamoto Y; Sasaki K; Toshimitsu S; Tatsugami F; Awai K; Hirokawa Y; Kihara Y
J Am Heart Assoc; 2018 Oct; 7(20):e010224. PubMed ID: 30371290
[TBL] [Abstract][Full Text] [Related]
18. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study.
Derlin T; Tóth Z; Papp L; Wisotzki C; Apostolova I; Habermann CR; Mester J; Klutmann S
J Nucl Med; 2011 Jul; 52(7):1020-7. PubMed ID: 21680686
[TBL] [Abstract][Full Text] [Related]
19. Role of FDG PET/CT in investigating the mechanisms underlying atherosclerotic plaque formation and evolution.
Marzola MC; Saboury B; Chondrogiannis S; Rampin L; Grassetto G; Ferretti A; Alavi A; Rubello D
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):246-52. PubMed ID: 23726249
[TBL] [Abstract][Full Text] [Related]
20. Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques.
Lei-xing X; Jing-jing G; Jing-xue N; Juan W; Juan L; Chang-zai L; Xiao-xi W; Da-yi Y; Jia-jin L; Xiong-wei Z; Liu-quan C; Yong W; Dan-qing L; Hong-bin L
J Int Med Res; 2014 Feb; 42(1):213-23. PubMed ID: 24366494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
